MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC
Position in NVS — Novartis AG
CIK 1015877
ORLEANS, MA
Position in NVS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,092,936
+$384,923 QoQ
Shares Held
26,795
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.45%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC holds $3,410,790 across 4 Drug Manufacturers - General names.
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,092,936 | 26,795 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,708,013 | 26,895 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,463,121 | 27,005 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,437,289 | 28,405 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,172,163 | 28,455 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,720,301 | 27,955 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,212,508 | 27,930 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,994,719 | 28,130 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,721,014 | 28,130 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $2,860,480 | 28,330 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,876,526 | 28,240 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,839,607 | 28,140 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,588,880 | 28,140 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,735,208 | 30,150 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||